Friday, July 10, 2026

Drug profile · INN

linzagolix choline

linzagolix choline (YSELTY) is a gonadotropin-releasing hormone receptor antagonist.

EMA: approved Systemic hormonal preparations (H01) H01CC04
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — linzagolix choline
Class
Systemic hormonal preparations (H01)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

linzagolix choline (YSELTY) is a gonadotropin-releasing hormone receptor antagonist.

Key facts

INN linzagolix choline
Brand YSELTY
Mechanism Gonadotropin-releasing hormone receptor antagonist
Target Gonadotropin-releasing hormone receptor
Therapeutic class Systemic hormonal preparations (H01)
ATC code H01CC04

Mechanism of action

Gonadotropin-releasing hormone receptor antagonist

Primary target: Gonadotropin-releasing hormone receptor

Approval history

Authority Status Date
EMA approved

Related & competitor drugs

  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. cetrorelix acetate Gonadotropin-releasing hormone receptor antagonist
  3. colistimethate sodium Antiinfectives for systemic use (J01)
  4. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  5. daptomycin Antiinfectives for systemic use (J01)
  6. darunavir Antiinfectives for systemic use (J05)

Frequently asked questions

What is linzagolix choline?

linzagolix choline (YSELTY) is a gonadotropin-releasing hormone receptor antagonist.

What is the brand name for linzagolix choline?

YSELTY is a marketed brand name for linzagolix choline. Check FDA Drugs@FDA for the current US label holder and prescribing information.